Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
Iñaki Eguren‐Santamaría(Clinica Universidad de Navarra), José M. López-Picazo(Navarre Institute of Health Research), Ana Patiño‐García(Navarre Institute of Health Research), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Ignacio Gil‐Bazo(Navarre Institute of Health Research)
Cited by 13
Related Papers
KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target
|Molecular Cancer|2018|306
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma
|JAMA Oncology|2020|251
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor
|Expert Opinion on Investigational Drugs|2015|153
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
|Nature Communications|2019|146
Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)
|Critical Reviews in Oncology/Hematology|2020|135